| Name | Title | Contact Details |
|---|
The Y: Were for youth development, healthy living, and social responsibility
eDerm Systems is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Care New England Health System (CNE) and its member institutions—Butler Hospital, Women & Infants Hospital, Kent Hospital, Memorial Hospital, VNA of Care New England, The Providence Center and Care New England Wellness Center—are trusted organizations fueling the latest advances in medical research, attracting the nation`s top specialty-trained doctors, and honing renowned services and innovative programs to engage in the important discussions people need to have about their health. Backed by a broad range of services—primary care, surgery, cardiovascular care, oncology, psychiatry, behavioral health, newborn pediatrics and the full spectrum of women`s health services—CNE is reinventing the way health care is delivered, partnering with our patients to provide the best care possible while working to create a community of healthier people. To that end, we are committed to a culture of accountability, caring and teamwork. We called it ACT values. These values were not defined by senior management but through a comprehensive process with our employees who identified these values as tangible and important to the cohesiveness of the entire organization. They are embedded into everything we do, working with patients and their families, and with each other.
ABCOMM is a Champaign, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Repertoire Immune Medicines is working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions, and infectious diseases. Repertoire scientists created and developed a suite of technologies for its DECODE discovery and DEPLOY product platforms that allow in-depth characterization of the immune synapse and the ability to rationally design, and clinically develop, multi-clonal immune medicines. The company is currently conducting experimental medicine clinical trials using autologous T cells primed against cancer antigens and tethered to IL-15.